The U.S. District Court for the District of New Jersey has approved a proposed $14.1 million class action settlement for investors who purchased TAL Education Group American Depositary Shares (ADS) between January 14, 2022, and March 14, 2023. The settlement hearing is scheduled for October 29, 2026, to determine if the deal is fair and to approve attorneys' fees and distribution plans. Investors who held TAL ADS through March 14, 2023, may submit claims to share in the settlement fund. Those wishing to exclude themselves or object must do so by specified deadlines. This settlement resolves claims against TAL related to the ADS purchases during the specified period.
Esperion Therapeutics presented new data at the 2026 European Atherosclerosis Society Congress showing bempedoic acid effectively lowers LDL cholesterol in children aged 6-17 with familial hypercholesterolemia and is well tolerated. A secondary analy...
Auditoria.AI introduced Governed Autonomy, a new framework allowing AI agents to operate within enterprise-defined policies in finance, reducing the need for human approval on every transaction. This shift addresses governance challenges in AI deploy...
Rhythm Pharmaceuticals announced that its CEO and CFO will participate in fireside chats at the Jefferies Global Healthcare Conference on June 4 and the Goldman Sachs Global Healthcare Conference on June 8, 2026. These events will be webcast and acce...
Rani Therapeutics Holdings, a clinical-stage biotherapeutics company, announced a registered direct offering of Class A common stock priced at-the-market under Nasdaq rules. The offering includes 12.48 million shares and pre-funded warrants for 6.21 ...
Microchip Technology has introduced new 3.3 kV HV-D3 mSiC power modules designed to enhance solid-state transformers (SSTs) for AI hyperscale data centers. These modules integrate silicon carbide MOSFETs and Schottky diodes to improve power delivery ...
